Human CD34+/KDR+ cells are generated from circulating CD34+ cells after immobilization on activated platelets.
de Boer
H C
HC
Department of Nephrology, Leiden University Medical Center, Albinusdreef 2, Leiden, the Netherlands.
Hovens
M M
MM
van Oeveren-Rietdijk
A M
AM
Snoep
J D
JD
de Koning
E J P
EJ
Tamsma
J T
JT
Huisman
M V
MV
Rabelink
A J
AJ
van Zonneveld
A J
AJ
D018952:Antigens, CD34 / Q000378:metabolism*; D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism*; D016022:Case-Control Studies; D002450:Cell Communication / Q000502:physiology; D002454:Cell Differentiation / Q000502:physiology*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood; D011992:Endosomes / Q000378:metabolism; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D039902:Multipotent Stem Cells / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism*; D019007:P-Selectin / Q000378:metabolism; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D015539:Platelet Activation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology; D019718:Receptors, CXCR4 / Q000378:metabolism; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000378:metabolism*
D018952:Antigens, CD34; C514936:CXCR4 protein, mouse; D019007:P-Selectin; D010975:Platelet Aggregation Inhibitors; D019718:Receptors, CXCR4; D019869:Phosphatidylinositol 3-Kinases; D040301:Vascular Endothelial Growth Factor Receptor-2; D001241:Aspirin